首页 > 最新文献

The clinical investigator最新文献

英文 中文
Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome. 原发性Sjögren综合征周围神经病变的神经生理学评估。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190735
M Denislic, D Meh

Peripheral nervous system complications are rare in patients with primary Sjögren's syndrome. We investigated a group of six women aged 43-64 years who complained of pain and sensory symptoms. Conventional neurophysiological tests reflecting large nerve fiber function revealed normal motor conduction in all patients, whereas sensory nerve action potentials were absent in two. On the other hand, quantitative thermometry and autonomic nerve function tests indicating small nerve fiber function were more sensitive in the assessment of nerve dysfunction; these showed abnormalities in all cases. Vibrametry showed dysfunctions in four patients. The latter methods possess great sensitivity in discovering sensory disturbances. Neurophysiological assessment of the sensory and autonomic nervous system demonstrating sensory neuropathy contributes to early diagnosis of primary Sjögren's syndrome.

周围神经系统并发症是罕见的患者原发性Sjögren's综合征。我们调查了一组6名年龄在43-64岁的女性,她们抱怨疼痛和感觉症状。常规神经生理测试显示,所有患者的大神经纤维功能显示运动传导正常,而2例患者的感觉神经动作电位缺失。另一方面,定量测温和自主神经功能测试提示小神经纤维功能对神经功能障碍的评估更为敏感;所有病例均显示异常。振动测量显示4例患者功能障碍。后一种方法在发现感觉障碍方面具有很高的灵敏度。感觉和自主神经系统的神经生理学评估显示感觉神经病变有助于早期诊断原发性Sjögren综合征。
{"title":"Neurophysiological assessment of peripheral neuropathy in primary Sjögren's syndrome.","authors":"M Denislic,&nbsp;D Meh","doi":"10.1007/BF00190735","DOIUrl":"https://doi.org/10.1007/BF00190735","url":null,"abstract":"<p><p>Peripheral nervous system complications are rare in patients with primary Sjögren's syndrome. We investigated a group of six women aged 43-64 years who complained of pain and sensory symptoms. Conventional neurophysiological tests reflecting large nerve fiber function revealed normal motor conduction in all patients, whereas sensory nerve action potentials were absent in two. On the other hand, quantitative thermometry and autonomic nerve function tests indicating small nerve fiber function were more sensitive in the assessment of nerve dysfunction; these showed abnormalities in all cases. Vibrametry showed dysfunctions in four patients. The latter methods possess great sensitivity in discovering sensory disturbances. Neurophysiological assessment of the sensory and autonomic nervous system demonstrating sensory neuropathy contributes to early diagnosis of primary Sjögren's syndrome.</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190735","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892461","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Determination of DNA single-strand breaks in lymphocytes of smokers and nonsmokers exposed to environmental tobacco smoke using the nick translation assay. 利用缺口翻译试验测定暴露于环境烟草烟雾的吸烟者和非吸烟者淋巴细胞DNA单链断裂。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190755
M Einhaus, O Holz, R Meissner, T Krause, K Warncke, I Held, G Scherer, A R Tricker, F Adlkofer, H W Rüdiger

The detection of DNA single-strand breaks (SSB) in human mononucleated white blood cells (MWBC) using a modified version of the nick translation assay is presented. This assay allows rapid and sensitive examination of SSB using only 5 ml heparinized blood for an eightfold determination. The assay was standardized by incubation of MBWC in vitro with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), a known genotoxic agent. In vitro incubation of MWBC with MNNG induced a dose-dependent increase in DNA-SSB at doses between 5 and 500 microM MNNG. The detection limit for the assay was 5 microM MNNG. To assess the suitability of this assay to detect SSB in vivo a controlled study was performed in which volunteer smokers (n = 5), nonsmokers (n = 5) exposed to environmental tobacco smoke (ETS), and nonsmokers controls (n = 5) were compared. The study lasted 4 experimental days, 2 control and 2 exposure days. On control days (days 1 and 3) smokers and nonsmokers sat in an unventilated 45 m3 room for 8 h. On the exposure days (days 2 and 4) each of the five smokers smoked 24 cigarettes in 8 h, while the five nonsmokers were exposed to the ETS generated by the smoking volunteers. High exposure to tobacco smoke was confirmed by dosimetry of carboxyhemoglobin (CO-Hb), plasma nicotine and cotinine levels. Blood was drawn before and after each exposure on all 4 experimental days for determination of DNA-SSB in lymphocytes immediately after isolation of blood cells.(ABSTRACT TRUNCATED AT 250 WORDS)

在人类单核白细胞(MWBC) DNA单链断裂(SSB)的检测使用改进版本的缺口翻译试验提出。该试验允许快速和敏感的检查SSB只使用5毫升肝素化血8倍测定。用已知基因毒性物质n -甲基-n′-硝基-n -亚硝基胍(MNNG)体外孵育MBWC,使该方法标准化。MWBC与MNNG的体外孵育诱导了5至500微米MNNG剂量下DNA-SSB的剂量依赖性增加。该方法的检出限为5 μ m - MNNG。为了评估该方法在体内检测SSB的适用性,我们进行了一项对照研究,将自愿吸烟者(n = 5)、暴露于环境烟草烟雾(ETS)的非吸烟者(n = 5)和非吸烟者对照(n = 5)进行比较。试验期4 d,对照组2 d,暴露期2 d。在对照日(第1天和第3天),吸烟者和不吸烟者在不通风的45立方米房间里坐8小时。在暴露日(第2天和第4天),5名吸烟者在8小时内每人吸24支烟,而5名不吸烟者暴露在吸烟志愿者产生的ETS中。通过碳氧血红蛋白(CO-Hb)、血浆尼古丁和可替宁水平的剂量测定证实了高暴露于烟草烟雾。在所有4天的实验中,每次暴露前后均抽血,在血细胞分离后立即测定淋巴细胞中的DNA-SSB。(摘要删节250字)
{"title":"Determination of DNA single-strand breaks in lymphocytes of smokers and nonsmokers exposed to environmental tobacco smoke using the nick translation assay.","authors":"M Einhaus,&nbsp;O Holz,&nbsp;R Meissner,&nbsp;T Krause,&nbsp;K Warncke,&nbsp;I Held,&nbsp;G Scherer,&nbsp;A R Tricker,&nbsp;F Adlkofer,&nbsp;H W Rüdiger","doi":"10.1007/BF00190755","DOIUrl":"https://doi.org/10.1007/BF00190755","url":null,"abstract":"<p><p>The detection of DNA single-strand breaks (SSB) in human mononucleated white blood cells (MWBC) using a modified version of the nick translation assay is presented. This assay allows rapid and sensitive examination of SSB using only 5 ml heparinized blood for an eightfold determination. The assay was standardized by incubation of MBWC in vitro with N-methyl-N'-nitro-N-nitrosoguanidine (MNNG), a known genotoxic agent. In vitro incubation of MWBC with MNNG induced a dose-dependent increase in DNA-SSB at doses between 5 and 500 microM MNNG. The detection limit for the assay was 5 microM MNNG. To assess the suitability of this assay to detect SSB in vivo a controlled study was performed in which volunteer smokers (n = 5), nonsmokers (n = 5) exposed to environmental tobacco smoke (ETS), and nonsmokers controls (n = 5) were compared. The study lasted 4 experimental days, 2 control and 2 exposure days. On control days (days 1 and 3) smokers and nonsmokers sat in an unventilated 45 m3 room for 8 h. On the exposure days (days 2 and 4) each of the five smokers smoked 24 cigarettes in 8 h, while the five nonsmokers were exposed to the ETS generated by the smoking volunteers. High exposure to tobacco smoke was confirmed by dosimetry of carboxyhemoglobin (CO-Hb), plasma nicotine and cotinine levels. Blood was drawn before and after each exposure on all 4 experimental days for determination of DNA-SSB in lymphocytes immediately after isolation of blood cells.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190755","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18893447","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Disseminated histoplasmosis in a non-immunocompromised host. 非免疫功能低下宿主的播散性组织浆菌病。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190745
P Harten, H H Euler, E Wolf, G Delling, H Löffler

Histoplasma infections in Europe are rare, and acute disseminated histoplasmosis has only been observed in immunocompromised persons. We describe a case of acute disseminated histoplasmosis in a young, nonimmunocompromised European woman. The probable source of infection was Sri Lanka or the Maldives. At presentation she was severely ill with fever, lymphadenopathy, anemia, thrombocytopenia, hepatosplenomegaly, and polyserositis. Histologically, myelofibrosis and osteosclerosis were observed with extramedullary hematopoiesis. Histoplasma capsulatum yeasts were detected in bone marrow trephine biopsy by methenamine silver staining. Treatment with conventional and liposomal amphotericin B and subsequent itraconazole led to rapid and complete recovery.

组织浆体感染在欧洲是罕见的,急性播散性组织浆体病只在免疫功能低下的人群中观察到。我们描述一个病例急性播散性组织胞浆菌病在一个年轻的,非免疫功能低下的欧洲妇女。可能的传染源是斯里兰卡或马尔代夫。患者就诊时病情严重,伴有发热、淋巴结病、贫血、血小板减少、肝脾肿大和多发性浆液炎。组织学上,髓外造血观察到骨髓纤维化和骨硬化。用甲基苯丙胺银染色法在骨髓环钻活检组织中检测到荚膜组织浆酵母。常规治疗和两性霉素B脂质体治疗以及随后的伊曲康唑治疗使患者迅速完全康复。
{"title":"Disseminated histoplasmosis in a non-immunocompromised host.","authors":"P Harten,&nbsp;H H Euler,&nbsp;E Wolf,&nbsp;G Delling,&nbsp;H Löffler","doi":"10.1007/BF00190745","DOIUrl":"https://doi.org/10.1007/BF00190745","url":null,"abstract":"<p><p>Histoplasma infections in Europe are rare, and acute disseminated histoplasmosis has only been observed in immunocompromised persons. We describe a case of acute disseminated histoplasmosis in a young, nonimmunocompromised European woman. The probable source of infection was Sri Lanka or the Maldives. At presentation she was severely ill with fever, lymphadenopathy, anemia, thrombocytopenia, hepatosplenomegaly, and polyserositis. Histologically, myelofibrosis and osteosclerosis were observed with extramedullary hematopoiesis. Histoplasma capsulatum yeasts were detected in bone marrow trephine biopsy by methenamine silver staining. Treatment with conventional and liposomal amphotericin B and subsequent itraconazole led to rapid and complete recovery.</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190745","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study. LDL分离对家族性高胆固醇血症患者冠状动脉疾病进展的影响一项多中心LDL分离研究的结果。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190741
T Waidner, D Franzen, W Voelker, M Ritter, H Borberg, V Hombach, H W Höpp

This study investigated the effect of extracorporal lipid-lowering therapy by low-density lipoprotein (LDL) apheresis on coronary artery disease in a population characterized by early development and rapid progression of atherosclerosis. We treated 32 patients aged between 15 and 63 years with drug-refractory familial hypercholesterolemia, treated once a week by immuno-specific LDL apheresis for 3 years in a controlled prospective and non-randomized trial; 25 patients (14 females and 11 males) completed the study. Noninvasive data were obtained by physical examination, 12-lead ECG and exercise testing. Invasive cardiological data were obtained by cardiac catheterization according to a standardized protocol in four cardiological centers. Left ventricular ejection fraction was calculated using planimetry. Coronary stenoses were measured quantitatively in 23 defined coronary segments by a panel of four investigators with an electronic digital caliper. In addition, overall coronary atherosclerosis was visually qualified. Final decisions on a classification into one of three groups (regression, no change, progression) of coronary atherosclerosis were based on panel consensus. Six cardiac events occurred throughout the study: percutaneous transluminal coronary angioplasty in one patient, coronary bypass grafting in three and two deaths. Statistical analysis of exercise testing yielded no significant change for maximum power and work capacity during the study period. Hemodynamic data revealed no significant change; mean ejection fraction was calculated as 65.8 +/- 15.9% at study entry and 67.0 +/- 12.7% at completion. Quantitative measurement of 111 circumscribed coronary stenoses showed a mean stenosis degree of 45 +/- 26% at entry cineangio-film and 43 +/- 22% at final cineangio-film demonstrating no significant change.(ABSTRACT TRUNCATED AT 250 WORDS)

本研究探讨了低密度脂蛋白(LDL)分离体外降脂治疗对动脉粥样硬化早期发展和快速进展人群冠状动脉疾病的影响。在一项对照前瞻性和非随机试验中,我们治疗了32例年龄在15至63岁之间的药物难治性家族性高胆固醇血症患者,每周接受一次免疫特异性LDL分离治疗,持续3年;25例患者(女性14例,男性11例)完成了研究。通过体格检查、12导联心电图和运动试验获得无创资料。有创心脏学数据是根据四个心脏病中心的标准化协议通过心导管穿刺获得的。采用平面测量法计算左心室射血分数。冠状动脉狭窄由四名调查人员组成的小组用电子数字卡尺定量测量23个确定的冠状动脉段。此外,总体冠状动脉粥样硬化在视觉上是合格的。最终决定将冠状动脉粥样硬化分为三组(回归、不变、进展)。在整个研究过程中发生了6例心脏事件:1例经皮腔内冠状动脉成形术,3例冠状动脉搭桥术,2例死亡。运动测试的统计分析显示,在研究期间,最大功率和工作能力没有显著变化。血流动力学数据显示无明显变化;平均射血分数在研究开始时计算为65.8 +/- 15.9%,在研究结束时计算为67.0 +/- 12.7%。定量测量111例限定冠状动脉狭窄,入路血管片平均狭窄程度为45 +/- 26%,终路血管片平均狭窄程度为43 +/- 22%,无明显变化。(摘要删节250字)
{"title":"The effect of LDL apheresis on progression of coronary artery disease in patients with familial hypercholesterolemia. Results of a multicenter LDL apheresis study.","authors":"T Waidner,&nbsp;D Franzen,&nbsp;W Voelker,&nbsp;M Ritter,&nbsp;H Borberg,&nbsp;V Hombach,&nbsp;H W Höpp","doi":"10.1007/BF00190741","DOIUrl":"https://doi.org/10.1007/BF00190741","url":null,"abstract":"<p><p>This study investigated the effect of extracorporal lipid-lowering therapy by low-density lipoprotein (LDL) apheresis on coronary artery disease in a population characterized by early development and rapid progression of atherosclerosis. We treated 32 patients aged between 15 and 63 years with drug-refractory familial hypercholesterolemia, treated once a week by immuno-specific LDL apheresis for 3 years in a controlled prospective and non-randomized trial; 25 patients (14 females and 11 males) completed the study. Noninvasive data were obtained by physical examination, 12-lead ECG and exercise testing. Invasive cardiological data were obtained by cardiac catheterization according to a standardized protocol in four cardiological centers. Left ventricular ejection fraction was calculated using planimetry. Coronary stenoses were measured quantitatively in 23 defined coronary segments by a panel of four investigators with an electronic digital caliper. In addition, overall coronary atherosclerosis was visually qualified. Final decisions on a classification into one of three groups (regression, no change, progression) of coronary atherosclerosis were based on panel consensus. Six cardiac events occurred throughout the study: percutaneous transluminal coronary angioplasty in one patient, coronary bypass grafting in three and two deaths. Statistical analysis of exercise testing yielded no significant change for maximum power and work capacity during the study period. Hemodynamic data revealed no significant change; mean ejection fraction was calculated as 65.8 +/- 15.9% at study entry and 67.0 +/- 12.7% at completion. Quantitative measurement of 111 circumscribed coronary stenoses showed a mean stenosis degree of 45 +/- 26% at entry cineangio-film and 43 +/- 22% at final cineangio-film demonstrating no significant change.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190741","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension. 硝苯地平胃肠治疗系统早晚给药治疗原发性高血压的比较。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190742
P Greminger, P M Suter, D Holm, R Kobelt, W Vetter

The nifedipine gastrointestinal therapeutic system (GITS) is a recently developed controlled-release formulation for once-a-day dosing. We evaluated the influence of morning versus evening administration of the drug in a randomized double-blind cross-over study including 15 essential hypertensives. Five patients had to be excluded from blood pressure analysis because of noncompliance (three cases) or intolerable side effects (two cases). To assess the exact duration of the antihypertensive efficacy noninvasive automatic ambulatory blood pressure monitoring was performed. After a placebo period patients were given 30 mg nifedipine GITS either at 1000 or 2200 hours. Twenty-four-hours systolic and diastolic blood pressure profiles documented a sustained antihypertensive effect of both nifedipine regimens throughout the whole period without affecting the circadian rhythm. Statistical analysis revealed no significant difference between morning and evening administration. Two patients stopped their medication because of intolerable side effects (fatigue and muscle cramps, respectively). Two more cases suffered from mild reversible headache which provoked no discontinuation of the drug. In conclusion our results document a sustained antihypertensive efficacy of 30 mg nifedipine GITS in patients with moderate essential hypertension. Time of administration has no impact on day- and nighttime blood pressure control.

硝苯地平胃肠道治疗系统(GITS)是最近开发的控释制剂,每天一次给药。我们在一项包括15名原发性高血压患者的随机双盲交叉研究中评估了早晚给药的影响。5例患者因不符合要求(3例)或无法忍受的副作用(2例)而被排除在血压分析之外。为了评估降压疗效的确切持续时间,进行了无创自动动态血压监测。在安慰剂期后,患者在1000或2200小时给予30毫克硝苯地平GITS。24小时收缩压和舒张压记录了两种硝苯地平方案在整个期间持续的降压效果,而不影响昼夜节律。统计分析显示早晚用药无显著差异。两名患者因为无法忍受的副作用(分别是疲劳和肌肉痉挛)而停药。另外两例出现轻度可逆性头痛,没有引起停药。总之,我们的结果证明30mg硝苯地平GITS对中度原发性高血压患者有持续的降压效果。给药时间对白天和夜间血压控制没有影响。
{"title":"Morning versus evening administration of nifedipine gastrointestinal therapeutic system in the management of essential hypertension.","authors":"P Greminger,&nbsp;P M Suter,&nbsp;D Holm,&nbsp;R Kobelt,&nbsp;W Vetter","doi":"10.1007/BF00190742","DOIUrl":"https://doi.org/10.1007/BF00190742","url":null,"abstract":"<p><p>The nifedipine gastrointestinal therapeutic system (GITS) is a recently developed controlled-release formulation for once-a-day dosing. We evaluated the influence of morning versus evening administration of the drug in a randomized double-blind cross-over study including 15 essential hypertensives. Five patients had to be excluded from blood pressure analysis because of noncompliance (three cases) or intolerable side effects (two cases). To assess the exact duration of the antihypertensive efficacy noninvasive automatic ambulatory blood pressure monitoring was performed. After a placebo period patients were given 30 mg nifedipine GITS either at 1000 or 2200 hours. Twenty-four-hours systolic and diastolic blood pressure profiles documented a sustained antihypertensive effect of both nifedipine regimens throughout the whole period without affecting the circadian rhythm. Statistical analysis revealed no significant difference between morning and evening administration. Two patients stopped their medication because of intolerable side effects (fatigue and muscle cramps, respectively). Two more cases suffered from mild reversible headache which provoked no discontinuation of the drug. In conclusion our results document a sustained antihypertensive efficacy of 30 mg nifedipine GITS in patients with moderate essential hypertension. Time of administration has no impact on day- and nighttime blood pressure control.</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190742","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 42
European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia. 欧洲低密度脂蛋白受体缺陷研讨会。欧洲家族性高胆固醇血症工作组。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190749
H Schuster, S Humphries
{"title":"European workshop on LDL receptor defects. European Working Group on Familial Hypercholesterolaemia.","authors":"H Schuster,&nbsp;S Humphries","doi":"10.1007/BF00190749","DOIUrl":"https://doi.org/10.1007/BF00190749","url":null,"abstract":"","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190749","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18891657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Human leukocyte interferon-alpha in cream, for the treatment of genital warts in Asian women: a placebo-controlled, double-blind study. 人白细胞干扰素- α乳膏用于治疗亚洲女性生殖器疣:一项安慰剂对照的双盲研究。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190743
T A Syed, S Lundin, K M Cheema, B M Kahlon, R Cheema, S A Ahmad, M Ahmad

The purpose of this double-blind, placebo-controlled study was to determine and compare the clinical efficacy and tolerance of human leukocyte alpha-interferon (incorporated 2 x 10(6) IU/g) in hydrophilic cream to cure genital warts. Preselected Asian female patients (n = 150) aged 18-40 years (mean 22.5), with the clinical and biopsy-confirmed diagnosis of genital warts (mean 2.64), predominantly flat vaginal condylomas, were randomly allocated to 3 parallel groups. Each patient was given a coded tube containing 80 g placebo/active preparation with a graduated applicator. Patients were instructed to inject 6 g of the either alloted placebo/active cream deep into the vagina thrice a day for 3 consecutive days (group A) or 4 consecutive days (group B) per week, and if not cured the same treatment was extended to 3 more weeks (maximum 4 weeks active treatment). To assess the clinical efficacy patients were examined on a week-to-week basis. A total clearance of warts (biopsy-confirmed) was evaluated as a complete cure. Patients cured during the treatment were spared further treatment and were requested to visit us after 16 weeks for relapse control. As for the remaining patients, empty tubes were collected, and similarly coded replacement tubes were given for further treatment (in total 588 tubes were used). By the end of the treatment 57.2% lesions (227/397) were eliminated in all the groups: 48% patients in group A, 90% patients in group B, and 10% patients in placebo groups taken as completely cured.(ABSTRACT TRUNCATED AT 250 WORDS)

这项双盲、安慰剂对照研究的目的是确定和比较人白细胞α -干扰素(加入2 × 10(6) IU/g)在亲水乳膏中治疗生殖器疣的临床疗效和耐受性。预先选择年龄在18-40岁(平均22.5岁)、临床和活检确诊为尖锐湿疣(平均2.64岁)的亚洲女性患者(n = 150),随机分为3个平行组。每位患者被给予一个带有刻度的涂药器的装有80g安慰剂/活性制剂的编码管。患者被指示每天三次将分配的安慰剂/活性乳膏注射到阴道深处,连续3天(a组)或连续4天(B组),如果没有治愈,同样的治疗延长到3周(最多4周积极治疗)。为了评估临床疗效,对患者进行每周一次的检查。疣的完全清除(活检证实)被评估为完全治愈。治疗期间治愈的患者无需进一步治疗,并于16周后复诊控制复发。其余患者收集空管,并给予类似编码的替换管进行进一步治疗(共使用588根)。治疗结束时,所有组中57.2%的病变(227/397)被消除,其中A组48%,B组90%,安慰剂组10%为完全治愈。(摘要删节250字)
{"title":"Human leukocyte interferon-alpha in cream, for the treatment of genital warts in Asian women: a placebo-controlled, double-blind study.","authors":"T A Syed,&nbsp;S Lundin,&nbsp;K M Cheema,&nbsp;B M Kahlon,&nbsp;R Cheema,&nbsp;S A Ahmad,&nbsp;M Ahmad","doi":"10.1007/BF00190743","DOIUrl":"https://doi.org/10.1007/BF00190743","url":null,"abstract":"<p><p>The purpose of this double-blind, placebo-controlled study was to determine and compare the clinical efficacy and tolerance of human leukocyte alpha-interferon (incorporated 2 x 10(6) IU/g) in hydrophilic cream to cure genital warts. Preselected Asian female patients (n = 150) aged 18-40 years (mean 22.5), with the clinical and biopsy-confirmed diagnosis of genital warts (mean 2.64), predominantly flat vaginal condylomas, were randomly allocated to 3 parallel groups. Each patient was given a coded tube containing 80 g placebo/active preparation with a graduated applicator. Patients were instructed to inject 6 g of the either alloted placebo/active cream deep into the vagina thrice a day for 3 consecutive days (group A) or 4 consecutive days (group B) per week, and if not cured the same treatment was extended to 3 more weeks (maximum 4 weeks active treatment). To assess the clinical efficacy patients were examined on a week-to-week basis. A total clearance of warts (biopsy-confirmed) was evaluated as a complete cure. Patients cured during the treatment were spared further treatment and were requested to visit us after 16 weeks for relapse control. As for the remaining patients, empty tubes were collected, and similarly coded replacement tubes were given for further treatment (in total 588 tubes were used). By the end of the treatment 57.2% lesions (227/397) were eliminated in all the groups: 48% patients in group A, 90% patients in group B, and 10% patients in placebo groups taken as completely cured.(ABSTRACT TRUNCATED AT 250 WORDS)</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190743","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892428","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 7
Anecdotal evidence. 坊间证据。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190733
N Zöllner
{"title":"Anecdotal evidence.","authors":"N Zöllner","doi":"10.1007/BF00190733","DOIUrl":"https://doi.org/10.1007/BF00190733","url":null,"abstract":"","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190733","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892458","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hypertonic saline infusion induces activation of the lymphocyte Na+/H+ antiport and cytosolic alkalinization in healthy human subjects. 高渗生理盐水输注诱导健康人淋巴细胞Na+/H+抗体活化和胞质碱化。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190734
R Düsing, S Leibhammer, G Hoffmann, H Vetter, W Siffert

The Na+/H+ antiport is a membrane transport protein that extrudes intracellular protons in exchange for extracellular sodium. Some details of its physiological and pathophysiological role remain poorly defined. Experimental evidence suggests that the antiporter is involved in the regulation of cell volume. In the present study, we therefore investigated the activity of the lymphocyte Na+/H+ antiport in nine healthy volunteers following acute hypertonic (2.5%) saline infusion (4 mmol NaCl/kg over 120 min). Antiport activity was measured after acidifying the cells with Na+ propionate (5-40 mM) using the fluorescent dye bis-carboxyethyl carboxyfluorescein. Hypertonic saline induced significant increases in plasma osmolality (308.4 +/- 2.3 vs. 293.5 +/- 2.7 mOsm/kg; P < 0.01), serum Na+ (150.8 +/- 3.7 vs. 138.9 +/- 0.5 mmol/kg; P < 0.01), and Cl- concentrations (118.0 +/- 3.9 vs. 101.1 +/- 1.0 mmol/kg; P < 0.01). Extracellular hypertonicity was followed by a stimulated activity of the lymphocyte Na+/H+ antiport with an increase in the apparent Vmax values from 2.44 +/- 0.16 to 3.27 +/- 0.34 10(-3) s-1 (P < 0.01) and a slight rise in pK, from 6.81 +/- 0.03 to 6.87 +/- 0.03 (P < 0.05) after hypertonic saline. In addition to antiport activation, cytosolic alkalinization was observed with cytosolic pH values averaging 6.90 +/- 0.02 before and 6.99 +/- 0.02 (P < 0.01) after hypertonic saline. Our results show for the first time that acute extracellular hypertonicity in man due to hypertonic NaCl loading is associated with a stimulated lymphocyte Na+/H+ antiport activity and cytosolic alkalinization.

Na+/H+反端口是一种膜转运蛋白,它挤出细胞内的质子以换取细胞外的钠。其生理和病理生理作用的一些细节仍不清楚。实验证据表明,反向转运蛋白参与细胞体积的调节。因此,在本研究中,我们研究了9名健康志愿者在急性高渗(2.5%)生理盐水输注(4 mmol NaCl/kg超过120分钟)后淋巴细胞Na+/H+抗转运的活性。用荧光染料双羧基乙基羧基荧光素用钠+丙酸(5-40 mM)酸化细胞后测定抗港活性。高渗盐水诱导血浆渗透压显著升高(308.4 +/- 2.3 vs. 293.5 +/- 2.7 mOsm/kg;P < 0.01),血清钠+(150.8 + / - 3.7和138.9 + / - 0.5更易/公斤;P < 0.01), Cl-浓度(118.0 +/- 3.9 vs. 101.1 +/- 1.0 mmol/kg;P < 0.01)。细胞外高渗生理盐水刺激淋巴细胞Na+/H+反港活性,使Vmax从2.44 +/- 0.16增加到3.27 +/- 0.34 10(-3)s-1 (P < 0.01), pK从6.81 +/- 0.03增加到6.87 +/- 0.03 (P < 0.05)。除反port激活外,胞质碱化,高渗盐水处理前胞质pH平均为6.90 +/- 0.02,高渗盐水处理后胞质pH平均为6.99 +/- 0.02 (P < 0.01)。我们的研究结果首次表明,由于高渗NaCl负荷引起的急性细胞外高渗与刺激的淋巴细胞Na+/H+反港活性和细胞质碱化有关。
{"title":"Hypertonic saline infusion induces activation of the lymphocyte Na+/H+ antiport and cytosolic alkalinization in healthy human subjects.","authors":"R Düsing,&nbsp;S Leibhammer,&nbsp;G Hoffmann,&nbsp;H Vetter,&nbsp;W Siffert","doi":"10.1007/BF00190734","DOIUrl":"https://doi.org/10.1007/BF00190734","url":null,"abstract":"<p><p>The Na+/H+ antiport is a membrane transport protein that extrudes intracellular protons in exchange for extracellular sodium. Some details of its physiological and pathophysiological role remain poorly defined. Experimental evidence suggests that the antiporter is involved in the regulation of cell volume. In the present study, we therefore investigated the activity of the lymphocyte Na+/H+ antiport in nine healthy volunteers following acute hypertonic (2.5%) saline infusion (4 mmol NaCl/kg over 120 min). Antiport activity was measured after acidifying the cells with Na+ propionate (5-40 mM) using the fluorescent dye bis-carboxyethyl carboxyfluorescein. Hypertonic saline induced significant increases in plasma osmolality (308.4 +/- 2.3 vs. 293.5 +/- 2.7 mOsm/kg; P < 0.01), serum Na+ (150.8 +/- 3.7 vs. 138.9 +/- 0.5 mmol/kg; P < 0.01), and Cl- concentrations (118.0 +/- 3.9 vs. 101.1 +/- 1.0 mmol/kg; P < 0.01). Extracellular hypertonicity was followed by a stimulated activity of the lymphocyte Na+/H+ antiport with an increase in the apparent Vmax values from 2.44 +/- 0.16 to 3.27 +/- 0.34 10(-3) s-1 (P < 0.01) and a slight rise in pK, from 6.81 +/- 0.03 to 6.87 +/- 0.03 (P < 0.05) after hypertonic saline. In addition to antiport activation, cytosolic alkalinization was observed with cytosolic pH values averaging 6.90 +/- 0.02 before and 6.99 +/- 0.02 (P < 0.01) after hypertonic saline. Our results show for the first time that acute extracellular hypertonicity in man due to hypertonic NaCl loading is associated with a stimulated lymphocyte Na+/H+ antiport activity and cytosolic alkalinization.</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190734","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Comparison of D2O and ethanol dilutions in total body water measurements in humans. D2O和乙醇在人体总水测量中的稀释度比较。
Pub Date : 1994-11-01 DOI: 10.1007/BF00190736
H G Endres, O Grüner

Total body water was measured by ethanol dilution and D2O stable isotope dilution in a group of 20 healthy volunteers (5 females and 15 males), predominantly 23- to 31-year-old students. Both indicator substances were given orally with an ethanol burden of 0.8 g/kg body weight and a D2O burden of 0.1 g/kg body weight after 12-h food and fluid restriction. This first direct comparison of total body water (TBW) from ethanol and D2O dilutions revealed the ethanol compartments to be smaller than those of D2O. The quotient of TBW (ethanol)/TBW (D2O) was 97.7%, which is the order of the quotient TBW (H2(18)O)/TBW (D2O) ( = 97%), well known from the literature and taken to represent relatively exactly the value of TBW overestimation (based on H/D exchange for acid protons) following D2O dilution [36]. Thus the value of TBW (ethanol) is almost identical to that of H2(18)O, which provides direct evidence that ethanol is distributed only in the body water.

用乙醇稀释法和D2O稳定同位素稀释法测量了20名健康志愿者(5名女性和15名男性)的总身体水分,主要是23至31岁的学生。两种指标物质均在限食限液12 h后,以0.8 g/kg体重的乙醇负荷和0.1 g/kg体重的D2O负荷口服。这是第一次直接比较乙醇和D2O稀释后的总水(TBW),结果显示乙醇的区室比D2O的小。TBW(乙醇)/TBW (D2O)的商数为97.7%,这与商数TBW (H2(18)O)/TBW (D2O)(= 97%)的数量级相同,该商数在文献中众所周知,可以相对准确地表示D2O稀释后TBW的高估值(基于酸质子的H/D交换)[36]。因此TBW(乙醇)的值与H2(18)O的值几乎相同,这就直接证明了乙醇只分布在体内的水中。
{"title":"Comparison of D2O and ethanol dilutions in total body water measurements in humans.","authors":"H G Endres,&nbsp;O Grüner","doi":"10.1007/BF00190736","DOIUrl":"https://doi.org/10.1007/BF00190736","url":null,"abstract":"<p><p>Total body water was measured by ethanol dilution and D2O stable isotope dilution in a group of 20 healthy volunteers (5 females and 15 males), predominantly 23- to 31-year-old students. Both indicator substances were given orally with an ethanol burden of 0.8 g/kg body weight and a D2O burden of 0.1 g/kg body weight after 12-h food and fluid restriction. This first direct comparison of total body water (TBW) from ethanol and D2O dilutions revealed the ethanol compartments to be smaller than those of D2O. The quotient of TBW (ethanol)/TBW (D2O) was 97.7%, which is the order of the quotient TBW (H2(18)O)/TBW (D2O) ( = 97%), well known from the literature and taken to represent relatively exactly the value of TBW overestimation (based on H/D exchange for acid protons) following D2O dilution [36]. Thus the value of TBW (ethanol) is almost identical to that of H2(18)O, which provides direct evidence that ethanol is distributed only in the body water.</p>","PeriodicalId":22408,"journal":{"name":"The clinical investigator","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"1994-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1007/BF00190736","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"18892463","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
期刊
The clinical investigator
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1